{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:40:19Z","timestamp":1754163619812,"version":"3.41.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Research Foundation of the Health Bureau of Jiangsu Province","award":["M202106","M2024084"],"award-info":[{"award-number":["M202106","M2024084"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103656"],"award-info":[{"award-number":["82103656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wuxi Municipal Science and Technology Development Planning Funds","award":["K20231034"],"award-info":[{"award-number":["K20231034"]}]},{"name":"Capability Enhancement Project of the Health Bureau of Jiangsu Province","award":["ZDXYS2022"],"award-info":[{"award-number":["ZDXYS2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02598-1","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:07:15Z","timestamp":1747109235000},"page":"1797-1810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lomibuvir sensitizes radioiodine-resistant thyroid cancer cell lines to radioiodine treatment by targeting hTERT RNA-dependent polymerase activity"],"prefix":"10.1007","volume":"48","author":[{"given":"Xian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiandong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-8833","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2598_CR1","doi-asserted-by":"publisher","first-page":"25538","DOI":"10.1038\/s41598-024-77663-5","volume":"14","author":"K Huang","year":"2024","unstructured":"Huang K, Huang X, Qian S, Cai Y, Wu F et al (2024) Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of disease study 2021. Sci Rep 14:25538. https:\/\/doi.org\/10.1038\/s41598-024-77663-5","journal-title":"Sci Rep"},{"key":"2598_CR2","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.3390\/curroncol31070286","volume":"31","author":"F Volpe","year":"2024","unstructured":"Volpe F, Nappi C, Zampella E, Di Donna E, Maurea S et al (2024) Current advances in radioactive Iodine-Refractory differentiated thyroid Cancer. Curr Oncol 31:3870\u20133884. https:\/\/doi.org\/10.3390\/curroncol31070286","journal-title":"Curr Oncol"},{"key":"2598_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2012-1038","volume":"34","author":"BR Haugen","year":"2013","unstructured":"Haugen BR, Sherman SI (2013) Evolving approaches to patients with advanced differentiated thyroid cancer. Endocr Rev 34:439\u2013455. https:\/\/doi.org\/10.1210\/er.2012-1038","journal-title":"Endocr Rev"},{"key":"2598_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ncpendmet0449","volume":"3","author":"M Schlumberger","year":"2007","unstructured":"Schlumberger M, Lacroix L, Russo D, Filetti S, Bidart JM (2007) Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nat Clin Pract Endocrinol Metab 3:260\u2013269. https:\/\/doi.org\/10.1038\/ncpendmet0449","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2598_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-0716-2505-7_17","volume":"2534","author":"WWL Chan","year":"2022","unstructured":"Chan WWL, Chan S, Kwong DLW (2022) Radioiodine refractory differentiated thyroid Cancer. Methods Mol Biol 2534:243\u2013257. https:\/\/doi.org\/10.1007\/978-1-0716-2505-7_17","journal-title":"Methods Mol Biol"},{"key":"2598_CR6","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn BC (2021) Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics 11:6251\u20136277. https:\/\/doi.org\/10.7150\/thno.57689","journal-title":"Theranostics"},{"key":"2598_CR7","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.drup.2023.100939","volume":"68","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang J, Hu X, Pan Z, Xu T et al (2023) Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy. Drug Resist Updat 68:100939. https:\/\/doi.org\/10.1016\/j.drup.2023.100939","journal-title":"Drug Resist Updat"},{"key":"2598_CR8","doi-asserted-by":"publisher","first-page":"589929","DOI":"10.3389\/fimmu.2020.589929","volume":"11","author":"M Dratwa","year":"2020","unstructured":"Dratwa M, Wysocza\u0144ska B, \u0141acina P, Kubik T, Bogunia-Kubik K (2020) TERT-Regulation and roles in Cancer formation. Front Immunol 11:589929. https:\/\/doi.org\/10.3389\/fimmu.2020.589929","journal-title":"Front Immunol"},{"key":"2598_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/ijms16011192","volume":"16","author":"T Lassmann","year":"2015","unstructured":"Lassmann T, Maida Y, Tomaru Y, Yasukawa M, Ando Y et al (2015) Telomerase reverse transcriptase regulates MicroRNAs. Int J Mol Sci 16:1192\u20131208. https:\/\/doi.org\/10.3390\/ijms16011192","journal-title":"Int J Mol Sci"},{"key":"2598_CR10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s41467-020-15289-7","volume":"11","author":"M Yasukawa","year":"2020","unstructured":"Yasukawa M, Ando Y, Yamashita T, Matsuda Y, Shoji S et al (2020) CDK1 dependent phosphorylation of hTERT contributes to cancer progression. Nat Commun 11:1557. https:\/\/doi.org\/10.1038\/s41467-020-15289-7","journal-title":"Nat Commun"},{"key":"2598_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature08283","volume":"461","author":"Y Maida","year":"2009","unstructured":"Maida Y, Yasukawa M, Furuuchi M, Lassmann T, Possemato R et al (2009) An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461:230\u2013235. https:\/\/doi.org\/10.1038\/nature08283","journal-title":"Nature"},{"key":"2598_CR12","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1128\/MCB.01021-15","volume":"36","author":"Y Maida","year":"2016","unstructured":"Maida Y, Yasukawa M, Masutomi K (2016) De Novo RNA synthesis by RNA-Dependent RNA polymerase activity of telomerase reverse transcriptase. Mol Cell Biol 36:1248\u20131259. https:\/\/doi.org\/10.1128\/MCB.01021-15","journal-title":"Mol Cell Biol"},{"key":"2598_CR13","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1128\/MCB.00093-14","volume":"34","author":"Y Maida","year":"2014","unstructured":"Maida Y, Yasukawa M, Okamoto N, Ohka S, Kinoshita K et al (2014) Involvement of telomerase reverse transcriptase in heterochromatin maintenance. Mol Cell Biol 34:1576\u20131593. https:\/\/doi.org\/10.1128\/MCB.00093-14","journal-title":"Mol Cell Biol"},{"key":"2598_CR14","first-page":"1050","volume":"114","author":"ID Hay","year":"1993","unstructured":"Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050\u20131057","journal-title":"Surgery"},{"key":"2598_CR15","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH et al (2005) Real-time quantification of MicroRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179. https:\/\/doi.org\/10.1093\/nar\/gni178","journal-title":"Nucleic Acids Res"},{"key":"2598_CR16","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.drup.2023.101013","volume":"72","author":"H Shen","year":"2024","unstructured":"Shen H, Zhu R, Liu Y, Hong Y, Ge J et al (2024) Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resist Updat 72:101013. https:\/\/doi.org\/10.1016\/j.drup.2023.101013","journal-title":"Drug Resist Updat"},{"key":"2598_CR17","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/ERC-17-0515","volume":"25","author":"A De la Vieja","year":"2018","unstructured":"De la Vieja A, Santisteban P (2018) Role of iodide metabolism in physiology and cancer. Endocr Relat Cancer 25:R225\u2013r245. https:\/\/doi.org\/10.1530\/ERC-17-0515","journal-title":"Endocr Relat Cancer"},{"key":"2598_CR18","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.2741\/4677","volume":"23","author":"S Benvenga","year":"2018","unstructured":"Benvenga S, Guarneri F (2018) Homology of Pendrin, sodium-iodide symporter and apical iodide transporter. Front Biosci (Landmark Ed) 23:1864\u20131873. https:\/\/doi.org\/10.2741\/4677","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2598_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","volume":"34","author":"J Liu","year":"2019","unstructured":"Liu J, Liu Y, Lin Y, Liang J (2019) Radioactive Iodine-Refractory differentiated thyroid Cancer and redifferentiation therapy. Endocrinol Metab (Seoul) 34:215\u2013225. https:\/\/doi.org\/10.3803\/EnM.2019.34.3.215","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2598_CR20","doi-asserted-by":"publisher","first-page":"154495","DOI":"10.1016\/j.prp.2023.154495","volume":"246","author":"L Zhang","year":"2023","unstructured":"Zhang L, Xu S, Cheng X, Wu J, Wang Y et al (2023) Inflammatory tumor microenvironment of thyroid cancer promotes cellular dedifferentiation and Silencing of iodide-handling genes expression. Pathol Res Pract 246:154495. https:\/\/doi.org\/10.1016\/j.prp.2023.154495","journal-title":"Pathol Res Pract"},{"key":"2598_CR21","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1111\/cas.14618","volume":"111","author":"M Machitani","year":"2020","unstructured":"Machitani M, Yasukawa M, Nakashima J, Furuichi Y, Masutomi K (2020) RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19. Cancer Sci 111:3976\u20133984. https:\/\/doi.org\/10.1111\/cas.14618","journal-title":"Cancer Sci"},{"key":"2598_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"key":"2598_CR23","doi-asserted-by":"publisher","first-page":"122110","DOI":"10.1016\/j.lfs.2023.122110","volume":"332","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Mahato RK, Singh S, Bhatti GK, Mastana SS et al (2023) Advances and challenges in thyroid cancer: the interplay of genetic modulators, targeted therapies, and AI-driven approaches. Life Sci 332:122110. https:\/\/doi.org\/10.1016\/j.lfs.2023.122110","journal-title":"Life Sci"},{"key":"2598_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-020-01757-x","volume":"39","author":"C Colombo","year":"2020","unstructured":"Colombo C, Minna E, Gargiuli C, Muzza M, Dugo M et al (2020) The molecular and gene\/mirna expression profiles of radioiodine resistant papillary thyroid cancer. J Exp Clin Cancer Res 39:245. https:\/\/doi.org\/10.1186\/s13046-020-01757-x","journal-title":"J Exp Clin Cancer Res"},{"key":"2598_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mc.23648","volume":"63","author":"D Wang","year":"2024","unstructured":"Wang D, Liu X, Li M, Ning J (2024) HIF-1\u03b1 regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2\/NF-\u03baB signaling pathway. Mol Carcinog 63:238\u2013252. https:\/\/doi.org\/10.1002\/mc.23648","journal-title":"Mol Carcinog"},{"key":"2598_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1507\/endocrj.EJ23-0136","volume":"70","author":"M Matsuse","year":"2023","unstructured":"Matsuse M, Mitsutake N (2023) TERT promoter mutations in thyroid cancer. Endocr J 70:1035\u20131049. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0136","journal-title":"Endocr J"},{"key":"2598_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu X, Bishop J, Shan Y, Pai S, Liu D et al (2013) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20:603\u2013610. https:\/\/doi.org\/10.1530\/ERC-13-0210","journal-title":"Endocr Relat Cancer"},{"key":"2598_CR28","doi-asserted-by":"publisher","first-page":"E1571","DOI":"10.1210\/jc.2014-1158","volume":"99","author":"N Wang","year":"2014","unstructured":"Wang N, Xu D, Sofiadis A, H\u00f6\u00f6g A, Vukojevi\u0107 V et al (2014) Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma. J Clin Endocrinol Metab 99:E1571\u20131579. https:\/\/doi.org\/10.1210\/jc.2014-1158","journal-title":"J Clin Endocrinol Metab"},{"key":"2598_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/d41573-024-00102-7","volume":"23","author":"A Mullard","year":"2024","unstructured":"Mullard A (2024) FDA approves first telomerase inhibitor. Nat Rev Drug Discov 23:570. https:\/\/doi.org\/10.1038\/d41573-024-00102-7","journal-title":"Nat Rev Drug Discov"},{"key":"2598_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41568-022-00490-1","volume":"22","author":"J Gao","year":"2022","unstructured":"Gao J, Pickett HA (2022) Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies. Nat Rev Cancer 22:515\u2013532. https:\/\/doi.org\/10.1038\/s41568-022-00490-1","journal-title":"Nat Rev Cancer"},{"key":"2598_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/path.5876","volume":"257","author":"Y Matsuda","year":"2022","unstructured":"Matsuda Y, Yamashita T, Ye J, Yasukawa M, Yamakawa K et al (2022) Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs. J Pathol 257:172\u2013185. https:\/\/doi.org\/10.1002\/path.5876","journal-title":"J Pathol"},{"key":"2598_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-024-06454-7","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Zhang Y, Jian Y, Gu L, Zhang D et al (2024) The regulations of telomerase reverse transcriptase (TERT) in cancer. Cell Death Dis 15:90. https:\/\/doi.org\/10.1038\/s41419-024-06454-7","journal-title":"Cell Death Dis"},{"key":"2598_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7065","author":"L Zhang","year":"2021","unstructured":"Zhang L, Xu S, Cheng X, Zheng J, Wang Y et al (2021) Diallyl trisulphide, a H(2) S donor, compromises the stem cell phenotype and restores thyroid-specific gene expression in anaplastic thyroid carcinoma cells by targeting AKT-SOX2 axis. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.7065","journal-title":"Phytother Res"},{"key":"2598_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41420-022-01232-w","volume":"8","author":"K Suzuki","year":"2022","unstructured":"Suzuki K, Tange M, Yamagishi R, Hanada H, Mukai S et al (2022) SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma. Cell Death Discov 8:446. https:\/\/doi.org\/10.1038\/s41420-022-01232-w","journal-title":"Cell Death Discov"},{"key":"2598_CR35","doi-asserted-by":"publisher","unstructured":"Fahim SA, ElZohairy YA, Moustafa RI (2024) Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition. Scientific Reports 14. https:\/\/doi.org\/10.1038\/s41598-024-51977-w","DOI":"10.1038\/s41598-024-51977-w"},{"key":"2598_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41388-023-02889-y","volume":"43","author":"H Lasolle","year":"2023","unstructured":"Lasolle H, Schiavo A, Tourneur A, Gillotay P, de Faria da Fonseca B et al (2023) Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids. Oncogene 43:155\u2013170. https:\/\/doi.org\/10.1038\/s41388-023-02889-y","journal-title":"Oncogene"},{"key":"2598_CR37","doi-asserted-by":"publisher","first-page":"770465","DOI":"10.3389\/fimmu.2022.770465","volume":"13","author":"CP Sun","year":"2022","unstructured":"Sun CP, Lan HR, Fang XL, Yang XY, Jin KT (2022) Organoid models for precision Cancer immunotherapy. Front Immunol 13:770465. https:\/\/doi.org\/10.3389\/fimmu.2022.770465","journal-title":"Front Immunol"},{"key":"2598_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JME-19-0198","volume":"65","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yun W, Shi B, Cui R, Liu C et al (2020) Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation. J Mol Endocrinol 65:1\u201310. https:\/\/doi.org\/10.1530\/JME-19-0198","journal-title":"J Mol Endocrinol"},{"key":"2598_CR39","doi-asserted-by":"publisher","first-page":"101588","DOI":"10.1016\/j.tranon.2022.101588","volume":"27","author":"M Liu","year":"2023","unstructured":"Liu M, Zhang L, Hu J, Yan C, Zhang Y et al (2023) LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p\/IMPA2 axis. Transl Oncol 27:101588. https:\/\/doi.org\/10.1016\/j.tranon.2022.101588","journal-title":"Transl Oncol"},{"issue":"17","key":"2598_CR40","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.3390\/cancers15174290","volume":"15","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2023","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Campenni A, de Keizer B, Deandreis D, Kreissl MC et al (2023) Molecular theranostics in Radioiodine-Refractory differentiated thyroid Cancer. Cancers (Basel) 15(17):4290. https:\/\/doi.org\/10.3390\/cancers15174290","journal-title":"Cancers (Basel)"},{"key":"2598_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12020-019-02167-6","volume":"68","author":"G Feng","year":"2020","unstructured":"Feng G, Luo Y, Zhang Q, Zeng F, Xu J et al (2020) Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis. Endocrine 68:56\u201363. https:\/\/doi.org\/10.1007\/s12020-019-02167-6","journal-title":"Endocrine"},{"key":"2598_CR42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1089\/thy.2023.0201","volume":"33","author":"V Gunda","year":"2023","unstructured":"Gunda V, Ghosh C, Hu J, Zhang L, Zhang YQ et al (2023) Combination BRAF(V600E) Inhibition with the multitargeting tyrosine kinase inhibitor axitinib shows additive anticancer activity in BRAF(V600E)-Mutant anaplastic thyroid Cancer. Thyroid 33:1201\u20131214. https:\/\/doi.org\/10.1089\/thy.2023.0201","journal-title":"Thyroid"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02598-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02598-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02598-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:56:31Z","timestamp":1753948591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02598-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2598"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02598-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}